Pettengell R - Search Results

1

Willis F, Pettengell R. Willis F, et al. Among authors: pettengell r. Expert Opin Biol Ther. 2002 Dec;2(8):985-92. doi: 10.1517/14712598.2.8.985. Expert Opin Biol Ther. 2002. PMID: 12517276 Review.

2

Pegfilgrastim successfully mobilizes megakaryocyte progenitors into the peripheral blood in subjects with solid tumours.

Willis F, Theti D, Dean S, Bacon P, Baker N, Pettengell R. Willis F, et al. Among authors: pettengell r. Bone Marrow Transplant. 2008 Aug;42(3):167-73. doi: 10.1038/bmt.2008.147. Epub 2008 May 26. Bone Marrow Transplant. 2008. PMID: 18500375 Clinical Trial.

3

Pegfilgrastim for peripheral CD34+ mobilization in patients with solid tumours.

Willis F, Woll P, Theti D, Jamali H, Bacon P, Baker N, Pettengell R. Willis F, et al. Among authors: pettengell r. Bone Marrow Transplant. 2009 Jun;43(12):927-34. doi: 10.1038/bmt.2008.411. Epub 2009 Jan 26. Bone Marrow Transplant. 2009. PMID: 19169289 Clinical Trial.

4

Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis.

Tooze JA, Hamzic E, Willis F, Pettengell R. Tooze JA, et al. Among authors: pettengell r. Cancer Genet. 2017 Dec;218-219:20-38. doi: 10.1016/j.cancergen.2017.09.002. Epub 2017 Sep 12. Cancer Genet. 2017. PMID: 29153094

5

Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma: results from an integrated analysis.

Pettengell R, Schwenkglenks M, Bacon P, Lawrinson S, Duehrsen U. Pettengell R, et al. Hematol Oncol. 2011 Dec;29(4):177-84. doi: 10.1002/hon.982. Epub 2011 Jan 18. Hematol Oncol. 2011. PMID: 21246591

6

Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.

Bouzar AB, Boxus M, Defoiche J, Berchem G, Macallan D, Pettengell R, Willis F, Burny A, Lagneaux L, Bron D, Chatelain B, Chatelain C, Willems L. Bouzar AB, et al. Among authors: pettengell r. Br J Haematol. 2009 Jan;144(1):41-52. doi: 10.1111/j.1365-2141.2008.07426.x. Epub 2008 Nov 1. Br J Haematol. 2009. PMID: 19006566 Free article.

7

Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience.

Renwick W, Pettengell R, Green M. Renwick W, et al. Among authors: pettengell r. BioDrugs. 2009;23(3):175-86. doi: 10.2165/00063030-200923030-00004. BioDrugs. 2009. PMID: 19627169 Review.

8

Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.

Pettengell R, Aapro M, Brusamolino E, Caballero D, Coiffier B, Pfreundschuh M, Trneny M, Walewski J. Pettengell R, et al. Clin Drug Investig. 2009;29(8):491-513. doi: 10.2165/00044011-200929080-00001. Clin Drug Investig. 2009. PMID: 19591512 Review.

9

Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor.

Pettengell R, Bias P, Mueller U, Lang N. Pettengell R, et al. Support Care Cancer. 2016 Jun;24(6):2677-84. doi: 10.1007/s00520-015-3057-2. Epub 2016 Jan 16. Support Care Cancer. 2016. PMID: 26780505

10

Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel.

Szlosarek PW, Lofts FJ, Pettengell R, Carter P, Young M, Harmer C. Szlosarek PW, et al. Among authors: pettengell r. Anticancer Drugs. 2000 Apr;11(4):275-8. doi: 10.1097/00001813-200004000-00008. Anticancer Drugs. 2000. PMID: 10898543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters